Cutting Edge: New Chimeric NOD2/TLR2 Adjuvant Drastically Increases Vaccine Immunogenicity-Reference-Cited by-同舟云学术

Cutting Edge: New Chimeric NOD2/TLR2 Adjuvant Drastically Increases Vaccine Immunogenicity

Published:2014-11-12 Issue:12 Volume:193 Page:5781-5785
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Pavot Vincent,Rochereau Nicolas,Rességuier Julien,Gutjahr Alice,Genin Christian,Tiraby Gerard,Perouzel Eric,Lioux Thierry,Vernejoul Fabienne,Verrier Bernard,Paul Stéphane

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference34 articles.

1. Vaccines for the 21st century

2. Use of defined TLR ligands as adjuvants within human vaccines

3. Unleashing the therapeutic potential of NOD-like receptors

4. Blueprints of Signaling Interactions between Pattern Recognition Receptors: Implications for the Design of Vaccine Adjuvants

5. Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and NOD1- and NOD2-activating agonists

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergistic immune augmentation enabled by covalently conjugating TLR4 and NOD2 agonists;European Journal of Medicinal Chemistry;2024-11

2. Chimeric NOD2 Mincle Agonists as Vaccine Adjuvants;Journal of Medicinal Chemistry;2024-03-20

3. Nanovaccines: An effective therapeutic approach for cancer therapy;Biomedicine & Pharmacotherapy;2024-01

4. Dual pattern recognition receptor ligands CL401, CL413, and CL429 as adjuvants for inactivated chikungunya virus;Virology;2023-08

5. Self-Adjuvanting Calcium-Phosphate-Coated Microcrystal-Based Vaccines Induce Pyroptosis in Human and Livestock Immune Cells;Vaccines;2023-07-11